Finance

Beta
Lists
C68:FRA
Crescent Biopharma Inc
€13.80
-13.21%
(-2.10) 1D
Jun 3, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for C68...
Open
€13.80
High
€13.80
Low
€13.80
Mkt. cap
495.60M
Avg. vol.
7.00
Volume
0.00
52-wk high
€22.80
52-wk low
€6.70
No. of employees
55
Open
€13.80
High
€13.80
Low
€13.80
Mkt. cap
495.60M
Avg. vol.
7.00
Volume
0.00
52-wk high
€22.80
52-wk low
€6.70
No. of employees
55
News stories
From sources across the web
About Crescent Biopharma Inc
CEO-
Employees55
Founded2024
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Websitecrescentbiopharma.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
10.84M
1.04M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
12.08M
20.35M
95.03M
17.90M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8.95M
5.54M
7.31M
7.86M
Operating expense
21.03M
25.88M
102.34M
25.77M
Total operating expenses
21.03M
25.88M
102.34M
25.77M
Operating income
-21.03M
-25.88M
-91.49M
-24.73M
Other non operating income
-
-
-
-
EBT including unusual items
-21.79M
-24.61M
-90.40M
-23.28M
EBT excluding unusual items
-21.79M
-24.61M
-90.40M
-23.28M
Income tax expense
-
-
2.00M
-
Effective tax rate
-
-
-2.21%
-
Other operating expenses
-
-
-
-
Net income
-21.79M
-24.61M
-92.40M
-23.28M
Net profit margin
-
-
-852.06%
-2,240.90%
Earnings per share
-3.72
-1.37
-4.92
-0.70
Interest and investment income
313.00K
1.28M
1.10M
1.45M
Interest expense
-1.07M
-
-
-
Net interest expenses
-760.00K
1.28M
1.10M
1.45M
Depreciation and amortization charges
-
-
-
-
EBITDA
-21.03M
-25.86M
-91.44M
-24.66M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer